Bright Green Corporation (BGXX)

USD 0.04

(0.0%)

Revenue Summary of Bright Green Corporation

  • Bright Green Corporation's latest annual revenue in 2023 was 401.49 Thousand USD , up 97.24% from previous year.
  • Bright Green Corporation's latest quarterly revenue in 2024 Q2 was - USD , down -100.0% from previous quarter.
  • Bright Green Corporation reported a annual revenue of 203.55 Thousand USD in annual revenue 2022, down 0.0% from previous year.
  • Bright Green Corporation reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Bright Green Corporation reported a quarterly revenue of 92.87 Thousand USD for 2024 Q1, up 1726.28% from previous quarter.
  • Bright Green Corporation reported a quarterly revenue of 165.3 Thousand USD for 2023 Q3, up 39.67% from previous quarter.

Annual Revenue Chart of Bright Green Corporation (2023 - 2019)

Historical Annual Revenue of Bright Green Corporation (2023 - 2019)

Year Revenue Revenue Growth
2023 401.49 Thousand USD 97.24%
2022 203.55 Thousand USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%

Peer Revenue Comparison of Bright Green Corporation

Name Revenue Revenue Difference
Collegium Pharmaceutical, Inc. 566.76 Million USD 99.929%
Embecta Corp. 1.12 Billion USD 99.964%
ANI Pharmaceuticals, Inc. 486.81 Million USD 99.918%
Dynavax Technologies Corporation 232.28 Million USD 99.827%
Esperion Therapeutics, Inc. 116.33 Million USD 99.655%
Pacira BioSciences, Inc. 674.97 Million USD 99.941%
PainReform Ltd. - USD -Infinity%
Aquestive Therapeutics, Inc. 50.58 Million USD 99.206%
Sunshine Biopharma, Inc. 24.09 Million USD 98.334%
SCYNEXIS, Inc. 140.14 Million USD 99.714%
China SXT Pharmaceuticals, Inc. 1.92 Million USD 79.181%
Cosmos Health Inc. 53.37 Million USD 99.248%
Journey Medical Corporation 79.18 Million USD 99.493%
Sunshine Biopharma, Inc. 24.09 Million USD 98.334%
Safety Shot Inc 202.67 Thousand USD -98.101%
Alpha Teknova, Inc. 36.68 Million USD 98.906%
Intra-Cellular Therapies, Inc. 464.37 Million USD 99.914%
Procaps Group, S.A. 409.92 Million USD 99.902%
Theratechnologies Inc. 81.76 Million USD 99.509%
Harrow Health, Inc. 130.19 Million USD 99.692%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD 96.847%
Biofrontera Inc. 34.07 Million USD 98.822%
DURECT Corporation 8.54 Million USD 95.303%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 99.934%
Cronos Group Inc. 88.84 Million USD 99.548%
OptiNose, Inc. 70.98 Million USD 99.434%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 99.909%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD 93.836%
Organogenesis Holdings Inc. 433.14 Million USD 99.907%
Guardion Health Sciences, Inc. 12.24 Million USD 96.722%
Cumberland Pharmaceuticals Inc. 39.55 Million USD 98.985%
Radius Health, Inc. 2.88 Billion USD 99.986%
Universe Pharmaceuticals INC 32.3 Million USD 98.757%
ProPhase Labs, Inc. 44.38 Million USD 99.095%
Phibro Animal Health Corporation 1.01 Billion USD 99.961%
Procaps Group S.A. 409.92 Million USD 99.902%
Alvotech 91.43 Million USD 99.561%
TherapeuticsMD, Inc. 1.3 Million USD 69.164%
Viatris Inc. 15.42 Billion USD 99.997%
Rockwell Medical, Inc. 83.61 Million USD 99.52%
Aytu BioPharma, Inc. 81 Million USD 99.504%
SIGA Technologies, Inc. 139.91 Million USD 99.713%
Tilray Brands, Inc. 788.94 Million USD 99.949%
Lifecore Biomedical, Inc. 128.26 Million USD 99.687%
Shineco, Inc. 9.8 Million USD 95.904%
PetIQ, Inc. 1.1 Billion USD 99.964%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -3245.758%
Neurocrine Biosciences, Inc. 1.88 Billion USD 99.979%
Alimera Sciences, Inc. 80.75 Million USD 99.503%
Silver Spike Investment Corp. 11.72 Million USD 96.575%
Assertio Holdings, Inc. 152.06 Million USD 99.736%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Petros Pharmaceuticals, Inc. 5.82 Million USD 93.104%
Clever Leaves Holdings Inc. 17.41 Million USD 97.695%
Cyclo Therapeutics, Inc. 1.07 Million USD 62.701%
Avadel Pharmaceuticals plc 27.96 Million USD 98.564%
Hempacco Co., Inc. 4.04 Million USD 90.076%
Talphera, Inc. 651 Thousand USD 38.327%
Alvotech 91.43 Million USD 99.561%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 99.873%
Lantheus Holdings, Inc. 1.29 Billion USD 99.969%
Currenc Group, Inc. 53.25 Million USD 99.246%
Kamada Ltd. 144.75 Million USD 99.723%
Indivior PLC 1.09 Billion USD 99.963%
Evoke Pharma, Inc. 5.18 Million USD 92.25%
Flora Growth Corp. 76.07 Million USD 99.472%
Cyclo Therapeutics, Inc. 1.07 Million USD 62.701%
Evolus, Inc. 202.08 Million USD 99.801%
HUTCHMED (China) Limited 837.99 Million USD 99.952%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 99.938%
Akanda Corp. 2.16 Million USD 81.413%